Work

564 Preclinical rationale for a first-in-human trial to evaluate the safety and preliminary efficacy of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) for mucosal pemphigus vulgaris

Year: 2020

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2020.03.574

Authors: A.S. Payne, J. Lee, D.K. Lundgren, X. Mao, S. Manfredo-Vieira, S. Nunez-Cruz, E.F. Williams, C. Assenmacher, E. Radaelli, B. Wang, C.T. Ellebrecht, J.A. Fraietta, M.C. Milone

Institution: University of Pennsylvania

Language: English

Topic: Autoimmune Bullous Skin Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3036686190

FWCI:

Cites:

Cited by:

Related to: 10